801 On Other Exchanges
801 is not on other exchanges.

golden meditech holdings ltd (801) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GOLDEN MEDITECH HOLDINGS LTD (801)

Related News

No related news articles were found.

golden meditech holdings ltd (801) Related Businessweek News

No Related Businessweek News Found

golden meditech holdings ltd (801) Details

Golden Meditech Holdings Limited, an investment holding company, operates as an integrated healthcare enterprise in the People’s Republic of China. It operates through five segments: Medical Devices, Hospital Management, Medical Insurance Administration, Chinese Herbal Medicines, and Cord Blood Storage. The Medical Devices segment develops, manufactures, and sells medical devices and medical accessories. This segment also offers blood related medical devices, such as Autologous Blood Recovery System and its consumables. The Hospital Management segment offers hospital management services; and operates two hospitals in Beijing and Shanghai that specializes in haematology and a range of medical disciplines. The Medical Insurance Administration segment provides medical insurance administration services. This segment also provides claim processing and bill settlement services to medical insurance companies, hospitals, and policy holders. The Chinese Herbal Medicine segment is involved in the research, development, manufacture, and sale of Chinese herbal medicines. The Cord Blood Bank segment provides cord blood stem cell examination, processing, separation, storage, and other related services. The company was formerly known as Golden Meditech Company Limited and changed its name to Golden Meditech Holdings Limited in March 2010. Golden Meditech Holdings Limited was incorporated in 2001 and is headquartered in Beijing, the People’s Republic of China.

736 Employees
Last Reported Date: 06/28/16
Founded in 2001

golden meditech holdings ltd (801) Top Compensated Officers

Founder, Chairman, Chief Executive Officer an...
Total Annual Compensation: $13.5M
Company Secretary and Executive Director
Total Annual Compensation: $12.0M
Total Annual Compensation: $555.0K
Compensation as of Fiscal Year 2016.

golden meditech holdings ltd (801) Key Developments

Golden Meditech Holdings Limited and MD Anderson Cancer Center Team Up to Create Cellenkos, Inc

Golden Meditech Holdings Limited and The University of Texas announced the creation of Cellenkos Inc. a start-up enterprise focused on umbilical cord blood derived T-regulatory cellular therapies. Cellenkos, to be based in Houston, is funded with an initial investment of USD 10 million with warrants to purchase an additional USD 10 million worth of shares by Golden Meditech and an independent strategic investor. The agreement covers technologies arising from the laboratory investigations of Simrit Parmar, M.D., associate professor in the Department of Stem Cell Transplantation and Cellular Therapy at MD Anderson. Cellenkos will build on Dr. Parmar's existing and potential future pre-clinical and clinical research to develop various T-reg-based therapies for clinical use in treating autoimmune diseases where the patient's T-reg cells are often defective and/or lower in number. These chronic and morbid diseases require long-term treatment with drugs that suppress the immune system that often have adverse side effects. Adoptive therapy with cord blood derived T-reg cells has the potential to replenish the immune system and impact patient care by providing novel, non-pharmacologic options.

Golden Meditech Holdings Limited, Annual General Meeting, Sep 28, 2016

Golden Meditech Holdings Limited, Annual General Meeting, Sep 28, 2016, at 10:00 China Standard Time. Location: No. 4 Yong Chang North Road Beijing Economic Technological Development Area Beijing China Agenda: To consider and adopt the audited consolidated financial statements of the company and its subsidiaries and the reports of the directors of the company and of the auditors for the year ended March 31, 2016; to consider re- election of executive and non-executive director; to consider the authorise the board of directors to fix the directors' remuneration; to consider the re-appoint the retiring auditors, KPMG, and to authorise the board to fix their remuneration; to consider the as special business, to consider and, if thought fit, pass with or without amendments; to grant a general mandate to the directors to allot, issue and deal with additional shares of the company; to consider the grant a general mandate to the directors to repurchase shares of the company; and to discuss other matters.

Golden Meditech Holdings Limited Announces Resignation of Yu Kwok Kuen, Harry as Director and Chief Operating Officer

The board of directors of Golden Meditech Holdings Limited announced that Mr. Yu Kwok Kuen, Harry resigned as an executive Director and Chief Operating Officer of the Company with effect from 30 June 2016 due to his decision to devote more time to his personal endeavours. The Board and Mr. Yu confirmed that there is no disagreement with each other and that there are no matters relating to Mr. Yu's resignation that need to be brought to the attention of the shareholders of the Company.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

801 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 801.
View Industry Companies

Industry Analysis


Industry Average

Valuation 801 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GOLDEN MEDITECH HOLDINGS LTD, please visit www.goldenmeditech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.